SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-003539
Filing Date
2022-02-09
Accepted
2022-02-09 09:03:11
Documents
26
Period of Report
2022-02-07
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 45782
2 ex99-1.htm EX-99.1 14280
3 ex99-1_001.jpg GRAPHIC 211918
4 ex99-1_002.jpg GRAPHIC 344041
5 ex99-1_003.jpg GRAPHIC 396254
6 ex99-1_004.jpg GRAPHIC 382753
7 ex99-1_005.jpg GRAPHIC 349532
8 ex99-1_006.jpg GRAPHIC 311057
9 ex99-1_007.jpg GRAPHIC 246517
10 ex99-1_008.jpg GRAPHIC 373945
11 ex99-1_009.jpg GRAPHIC 413671
12 ex99-1_010.jpg GRAPHIC 409421
13 ex99-1_011.jpg GRAPHIC 264182
14 ex99-1_012.jpg GRAPHIC 418106
15 ex99-1_013.jpg GRAPHIC 236905
  Complete submission text file 0001493152-22-003539.txt   6230946

Data Files

Seq Description Document Type Size
16 XBRL SCHEMA FILE otlc-20220207.xsd EX-101.SCH 3036
17 XBRL LABEL FILE otlc-20220207_lab.xml EX-101.LAB 34476
18 XBRL PRESENTATION FILE otlc-20220207_pre.xml EX-101.PRE 22597
20 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3293
Mailing Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301
Business Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301 650-635-7000
Oncotelic Therapeutics, Inc. (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21990 | Film No.: 22604024
SIC: 2834 Pharmaceutical Preparations